N-MYRISTOYLATION OF PROTEINS

THE ENZYME N-MYRISTOYL-TRANSFERASE

L. Tautz and J. Rétey


Introduction

A number of viral and eucaryotic proteins required for signal transduction and regulatory functions being important in cellular growth control, undergo a lipophilic modification by the enzyme N-myristoyl-transferase (Nmt). The lipid modification refers to the cotranslational transfer of myristiate from myristoyl-coenzyme A in amide linkage to the N-terminal glycine residue of the proteins (Figure 1). The usual irreversible modification is absolutely essential for the biological functions of most of these proteins. Attachment of the myristoyl residue provides hydrophobicity to influence the partitioning of proteins to cellular membranes and can serve to promote protein-protein interactions[1,2].
 

Figure 1: Nmt-Reaction

The necessity of N-myristoyl-proteins in various pathogenes, e.g. C. neoformans which causes  a fungal infection [3], or in viruses, e.g. HIV-I [4,5], Polio virus [6] and Hepatitis B virus [7], make Nmt as a suitable target for  anti-fungal and anti-viral agents [1,2].
N-myristoyl proteins are also found to be involved in carcinogenesis, e.g. in colon cancer, where increased synthesis of the oncogene product p60c-src - a tyrosine kinase - probably requires an increased level of N-myristoylation to facilitate the targeting of newly synthesized p60c-src to the cytoskeleton [8,9,10].

Development of an continious assay of Nmt activity based on fluorescence spectroscopy

Inspired of an assay for the enzyme farnesyl:protein transferase by Pompliano et al. [11], we have developed an efficient continuous assay based on fluorescence spectroscopy by using the increase in hydrophobicity about the reaction center of the acceptor substrate after fatty acid transfer. Change from a polar to nonpolar molecular enviroment causes an enhancement of fluorescence and an accompanying shift to lower wavelength emission maximum of certain fluorophores, like dansyl.

We designed the acceptor peptide substrate GSSK(dansyl)SKPK-NH2 (Figure 2), corresponding to the amino-terminus of the natural substrate p60src ö a tyrosine kinase [8]: Lysin was dansylated and the octapeptide was synthesized by using Fmoc-strategy with solid phase methods.
 

Figure 2: Dansylated octapeptide substrate GSSK(dansyl)SKPK-NH2 in enzyme reaction

The recombinand Nmt from S. cerevisiae, Nmt1p, which shows high sequence homology with the enzymes from mammals, was overexpressed in E. coli JM101 [12] and purified by gel chromatography.

Nmt1p was added to a solution of the dansylated peptide substrate and myristoyl coenzyme A in Tris buffer (pH7.5) at 30 °C. With excitation at 330 nm the increase of emission at 495 nm was measured (Figure 3).
 

Figure 3: fluorescence emission spectra with lex = 330 nm and lem = 495 nm

In the linear range of emission increase the enzyme follows the Michaelis Menten kinetic and the Km for the peptid was determined to be 25 µM.
Mechanistic investigations - synthesis of an nonhydrolysable substrate analogue

Myristoyl-carba(dethia)-coenzyme A 7 is a nonhydrolysable substrate analogue of myristoyl-coA. The sulfur atom is replaced by a methylene group. For mechanistic studies of catalysis with nuclear magnetic resonance spectroscopy the carbonyl C-atom shall be labeled with 13C-isotope. Therefore an efficient synthesis has been developed:
 

Figure 4: Synthesis of myristoyl-carba(dethia)-coenzyme A 7

The Synthesis was carried out with an over-all yield of 23 % referring to myristic acid 1.
References

[1] D.A. Rudnick, C.A. McWherter, G.W. Gokel, J.I. Gordon, Adv. Enzymol. Relat. Areas Mol. Biol. 1993, 67, 375-430
[2] D.R. Johnson, R.S. Bhatnagar, L.J. Knoll, J.I. Gordon, Annu. Rev. Biochem. 1994, 63, 869-914
[3] J.K. Lodge, E. Jackson-Machelski, D.L. Toffaletti, J.R. Perfect, J.I. Gordon, Proc. Natl. Acad. Sci. USA1994, 91, 12008-12012
[4] F.D. Veronese, T.D. Copeland, S. Oroszlan, R.C. Gallo, M.G. Sarngadharan, J. Virol. 1988, 62, 795-801
[5] H.G. Gottlinger, J.G. Sodroski, W.A. Haseltine, Proc. Natl. Acad. Sci. USA 1989, 86, 5781-5785
[6] M. Chow, J.F.E. Newman, D. Filman, J.M. Hogler, D.J. Rowlands, F. Brown, Nature 1987, 327, 482-486
[7] D.H. Pershing, H.E. Varmus, D. Ganem, J. Virol. 1987, 61, 1672-1677
[8] A.M. Schultz, L.E. Henderson, S. Oroszlan, E. Garber, H. Hanafusa, Science 1985, 227, 427-429
[9] G.A. Marchildon, J.E. Casnelli, K.A. Walsh, E.G. Krebs, Proc. Natl. Acad. Sci. USA 1984, 81, 7679-7682
[10] R.L. Felsted, C.J. Glover, K. Hartman, J. Nat. Canc. Inst. 1995, 87, 1571-1573
[11] D.L. Pompliano, R.P. Gomez, N.J. Anthony, J. Am. Chem. Soc. 1992, 114, 7945-7946
[12] R.J. Duronio, D.A. Rudnick, R.L. Johnson, M.E. Linder, J.I. Gordon, Methods Enzymol. 1990, 1, 253-263